Literature DB >> 31138900

HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.

Rodolfo B Serafim1, Cibele Cardoso1, Luis F M Di Cristofaro1, Christiane Pienna Soares2, Wilson Araújo Silva3,4,5, Enilza M Espreafico1, Maria L Paçó-Larson1, Brendan D Price6, Valeria Valente7,8,9.   

Abstract

The Holliday Junction-Recognition Protein (HJURP) was reported as overexpressed in several cancers and also strongly correlated with poor prognosis of patients, especially in glioblastoma (GBM), the most common and deadly type of primary brain tumor. HJURP is responsible for loading the histone H3 variant-the Centromeric Protein A (CENP-A)-at the centromeres in a cell cycle-regulated manner, being required for proper chromosome segregation. Here we investigated HJURP association with survival and radioresistance of different GBM cell lines. HJURP knockdown compromised the clonogenic capacity and severely impaired survival of five distinct GBM cells, while nontumor astrocytes were not affected. U251MG cells showed a robust cell cycle arrest in G2/M phases followed by a drastic increment in cell death after HJURP silencing, while U138MG and U343MG cell lines presented augmented senescence with a comparable increase in cell death. Importantly, we verified that the impact on cell cycle dynamics and clonogenic survival were associated with loss CENP-A at the centromeres. Moreover, radiation resistance was also impacted by HJURP modulation in several GBM cell lines. U87MG, T98G, U138MG, and U343MG cells were all sensitized to ionizing radiation after HJURP reduction. These data reinforce the requirement of HJURP for proliferative capacity and radioresistance of tumor cells, underlining its potential as a promising therapeutic target for GBM.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31138900     DOI: 10.1038/s41417-019-0103-0

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  5 in total

1.  HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer.

Authors:  Misha Mao; Yunlu Jia; Yongxia Chen; Jingjing Yang; Ling Xu; Xun Zhang; Jichun Zhou; Zhaoqing Li; Cong Chen; Siwei Ju; Linbo Wang
Journal:  Cell Death Dis       Date:  2022-04-22       Impact factor: 9.685

2.  HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer.

Authors:  Zhiyuan Dou; Chunping Qiu; Xun Zhang; Shu Yao; Chen Zhao; Zixiang Wang; Ran Chu; Jingying Chen; Zhongshao Chen; Rongrong Li; Kun Wang; Penglin Liu; Chang Liu; Kun Song; Beihua Kong
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.

Authors:  Zhaoshui Li; Zaiqi Ma; Hong Xue; Ruxin Shen; Kun Qin; Yu Zhang; Xin Zheng; Guodong Zhang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

4.  CENP-A is a potential prognostic biomarker and correlated with immune infiltration levels in glioma patients.

Authors:  Yuan Yang; Mengyun Duan; Yunfei Zha; Zijun Wu
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

5.  The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma.

Authors:  Yang Yang; Jinyan Yuan; Zhenzhong Liu; Wenwen Cao; Pei Liu
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.